In contrast to whole-body bioimpedance, which estimates fluid status at a single point in time, thoracic bioimpedance applied by a wearable device could enable continuous measurements. However, clinical experience with thoracic bioimpedance in patients in dialysis is still limited. In order to test the reproducibility of whole-body and thoracic bioimpedance measurements and to compare their relation with hemodynamic changes during hemodialysis, these parameters were measured pre- and end-dialysis in 54 patients during two sessions. Bioimpedance signals from both devices were moderately reproducible between two dialysis sessions (intraclass correlation of delta whole-body and thoracic resistance between session 1 and 2 was .711 [.58 - .8] and .723 [.6 - .81] respectively). There was a very high - high correlation between ultrafiltration volume and relative whole-body, respectively thoracic bioimpedance. Changes in systolic blood pressure negatively correlated to both bioimpedance techniques. Whereas the relation with ultrafiltration volume and changes in resistance was stronger for whole-body bioimpedance, the relation with changes in blood pressure was at least comparable for thoracic measurements. These results suggest that thoracic bioimpedance measurements by a wearable device may serve as an interesting alternative to whole-body measurements for continuous hemodynamic monitoring during hemodialysis.